Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 4
2007 4
2008 2
2009 8
2010 14
2011 20
2012 12
2013 15
2014 18
2015 26
2016 31
2017 28
2018 25
2019 19
2020 31
2021 16
2022 23
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Results by year

Filters applied: . Clear all
Page 1
Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
Izadi S, Moslehi A, Kheiry H, Kiani FK, Ahmadi A, Masjedi A, Ghani S, Rafiee B, Karpisheh V, Hajizadeh F, Atyabi F, Assali A, Tekie FSM, Namdar A, Ghalamfarsa G, Sojoodi M, Jadidi-Niaragh F. Izadi S, et al. Among authors: atyabi f. Pharm Res. 2022 Dec;39(12):3383-3384. doi: 10.1007/s11095-022-03432-6. Pharm Res. 2022. PMID: 36369589 No abstract available.
Clinical applications of nanomedicine in cancer therapy.
Norouzi M, Amerian M, Amerian M, Atyabi F. Norouzi M, et al. Among authors: atyabi f. Drug Discov Today. 2020 Jan;25(1):107-125. doi: 10.1016/j.drudis.2019.09.017. Epub 2019 Oct 3. Drug Discov Today. 2020. PMID: 31586642 Review.
Interleukin-6 participation in pathology of ocular diseases.
Zahir-Jouzdani F, Atyabi F, Mojtabavi N. Zahir-Jouzdani F, et al. Among authors: atyabi f. Pathophysiology. 2017 Sep;24(3):123-131. doi: 10.1016/j.pathophys.2017.05.005. Epub 2017 Jun 10. Pathophysiology. 2017. PMID: 28629694 Free article. Review.
Prospects of siRNA applications in regenerative medicine.
Mottaghitalab F, Rastegari A, Farokhi M, Dinarvand R, Hosseinkhani H, Ou KL, Pack DW, Mao C, Dinarvand M, Fatahi Y, Atyabi F. Mottaghitalab F, et al. Among authors: atyabi f. Int J Pharm. 2017 May 30;524(1-2):312-329. doi: 10.1016/j.ijpharm.2017.03.092. Epub 2017 Apr 4. Int J Pharm. 2017. PMID: 28385649 Review.
Appropriate Scaffold Selection for CNS Tissue Engineering.
Shafiee A, Ahmadi H, Taheri B, Hosseinzadeh S, Fatahi Y, Soleimani M, Atyabi F, Dinarvand R. Shafiee A, et al. Among authors: atyabi f. Avicenna J Med Biotechnol. 2020 Oct-Dec;12(4):203-220. Avicenna J Med Biotechnol. 2020. PMID: 33014312 Free PMC article. Review.
Tissue engineering: Still facing a long way ahead.
Hassanzadeh P, Atyabi F, Dinarvand R. Hassanzadeh P, et al. Among authors: atyabi f. J Control Release. 2018 Jun 10;279:181-197. doi: 10.1016/j.jconrel.2018.04.024. Epub 2018 Apr 13. J Control Release. 2018. PMID: 29655988 Review.
Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Salehi AM, Kheshti, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidi-Niaragh F. Salehi AM, et al. Among authors: atyabi f. Pharm Res. 2023 Feb;40(2):615-616. doi: 10.1007/s11095-022-03456-y. Pharm Res. 2023. PMID: 36477758 No abstract available.
258 results